At the Terasaki Innovation Summit 2024, we will present the Pavone, designed for translational research. It stands out by offering label-free biomarkers and supporting pre-clinical studies, aligning with the summit’s focus on innovative diagnostics and regenerative therapies. The Pavone enhances the precision of research outcomes by providing researchers with more physiologically relevant functional readouts, thereby streamlining the path from laboratory discoveries to clinical applications. This advance aims to elevate the success rate of clinical research, leading to more effective patient care solutions.
Arjunsinh Harer, Lauren Perez, and Kyle McGuire are set to attend the summit hosted at UCLA’s Luskin Conference Center.
